About US
Contact us
-
Immune-Onc and UT System to develop new biotherapeutics for cancer immunotherapyImmune-Onc Therapeutics has entered an agreement with two member institutions of the University of Texas System (UT System) to acquire the global rights to develop and commercialise new biotherapeutic2017/4/14
-
Synergy Pharmaceuticals launches new Poop Troop emoji keyboard app for CICUS-based Synergy Pharmaceuticals has launched a series of 14 animated emojis known as Poop Troop, designed to allow people to better express the physical and emotional impact of chronic idiopathic con2017/4/14
-
Kickbacks judge to Novartis: Hand over the info on those 79,000 'sham' eventsA U.S. judge has ordered Novartis to do something it’s been trying for a year to avoid: Hand over documents on 79,236 educational events the company says it held with doctors. Federal prosecutors cla2017/4/13
-
Democrats, Sanders back massive pharma overhaul in 'landmark' pricing legislationIn the wake of the Republicans' failure to repeal and replace the Affordable Care Act last week, Democrats are stepping in with some proposals of their own. A lot of proposals, in fact, in a"landmark"2017/4/13
-
Senate probe keeps heat on J&J, Mylan, Depomed and others for their opioid marketingOpioid makers have had no shortage of critics in recent years as the United States suffers the sting of a painful addiction epidemic. Now, a top senate Democrat is throwing the weight of her office be2017/4/12
-
Mylan's $465M settlement shortchanges taxpayers: studyWhen the U.S. government agreed on a $465 million Medicaid misclassification settlement with Mylan, did it agree on an amount that was too low? A new study says that’s likely the case. By calculating2017/4/12
-
Greece’s corruption prosecutor quits, citing pressure over Novartis bribery probeNovartis is embroiled in a soap opera in Greece, complete with bribery allegations and a suicide threat. Now the plot is thickening. The country’s chief corruption prosecutor, Eleni Raikou, has resign2017/4/11
-
Appeals court ruling resurrects 5,000 lawsuits tied to Merck & Co. Fosamax dangersThree years after a federal judge dismissed about 5,000lawsuits by patients claiming Merck & Co.’s osteoporosis drug Fosamax was responsible for their femur fractures, a higher court says Merck wi2017/4/11
-
Sanofi, Regeneron ask court to shield Dupixent from Amgen patent attackThe last time Sanofi and Regeneron launched a drug together, Amgen sued for patent infringement. Now, with an FDA decision on their key drug Dupixent due next week, the development partners are making2017/4/10
-
Judge in Japan lets Novartis off the hook in advertising scandalNovartis has escaped a false advertising charge in Japan tied to questionable data on its heart drug Diovan. It was one of a series of missteps for the Swiss company that culminated in a 15-daysuspens2017/4/10